Permanent cardiac pacing to prevent vasovagal syncope

Current Opinion in Cardiology

Volumn 17, Issue 1, 2002, Pages 90-95

  Raj, Satish R ^a   Sheldon, Robert S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; BRADYCARDIA; CLINICAL TRIAL; FEMALE; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SYNCOPE; TILT TABLE TEST; TREATMENT OUTCOME;

BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; HEART RATE; HUMANS; NORTH AMERICA; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; SENSORY THRESHOLDS; SYNCOPE, VASOVAGAL;

EID: 0036149205     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200201000-00013     Document Type: Review

References (33)

1. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker implantation)
2. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope
3. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope
4. Recurrence of neurocardiogenic syncope without pharmacologic interventions
5. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope
6. Permanent pacing for cardioinhibitory malignant vasovagal syndrome
7. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope
8. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
9. Impairment of physical and psychosocial function in recurrent syncope
10. The relationship between health-related quality of life and frequency of spells in patients with syncope
11. Heart periods during syncope: Holter analysis of patients with neurally mediated syncope
12. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker
13. Randomized assessment of syncope trial: Conventional diagnostic testing versus a prolonged monitoring strategy
14. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt
15. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope
16. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole
17. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope
18. Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result
19. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy - A multicenter randomized study
20. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: A multicenter, randomized, controlled trial
21. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope
22. Validation by serial standardized testing of a new rate-responsive pacemaker sensor based on variations in myocardial contractility
23. Simultaneous analysis of heart rate variability and myocardial contractility during head-up tilt in patients with vasovagal syncope
24. Autonomic nervous system-controlled cardiac pacing: A comparison between intracardiac impedance signal and muscle sympathetic nerve activity
25. Closed-loop stimulation using intracardiac impedance as a sensor principle: Correlation of right ventricular dP/dtmax and intracardiac impedance during dobutamine stress test
26. Detecting incipient vasovagal syncope: Intraventricular acceleration
27. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures
28. Efficacy of a patient-activated drug delivery system using phenylephrine as active drug in aborting tilt-induced syncope
29. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope
30. Diagnostic value of history in patients with syncope with or without heart disease
31. Historical diagnostic criteria for syncope versus seizures
32. Anamnestic diagnostic criteria for tilt-positive vasovagal syncope
33. Historical criteria for the causes of syncope in patients with structural heart disease